Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jul 8;11(1):14122.
doi: 10.1038/s41598-021-93728-1.

Relationship between serum total testosterone and prostate volume in aging men

Affiliations

Relationship between serum total testosterone and prostate volume in aging men

Bo-Wen Xia et al. Sci Rep. .

Abstract

Total testosterone levels decline with age, while prostate volume and the prevalence of benign prostatic hyperplasia increase with age. We sought to investigate the correlation of serum testosterone levels with prostate volume in aging men. We analyzed clinical data obtained from 416 ostensibly healthy men who underwent routine health check-ups and recruited and collected data from these subjects 4 years later. We analyzed the correlation between prostate volume and relevant factors, as well as the correlation between changes in prostate volume and low testosterone over a 4-year period. Men with low testosterone had significantly larger prostate volume than those in the normal testosterone group (26.86 ± 8.75 vs. 24.06 ± 6.77 P = 0.02), and subjects with low testosterone had significantly higher levels of obesity-related factors, including waist circumference, body mass index, and insulin (all P < 0.001). After adjustment for age, testosterone level was negatively correlated with prostate volume (P = 0.004), and prostate volume and 4-year changes in prostate volume were associated with low testosterone. With increased testosterone level, prostate volume showed a significant linear decreasing trend. These findings provide evidence of the relationship between testosterone and prostate volume. Additional large studies are needed to confirm these preliminary results.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Figure 1
Figure 1
Flow chart of selection of the included subjects.
Figure 2
Figure 2
Mean prostate volume and prostate volume after 4 years adjusted for age. White circle indicates mean. Lower and upper bar indicates 95% CI.

References

    1. McConnell JD, Roehrborn CG, Bautista OM, Andriole GJ, Dixon CM, Kusek JW, et al. The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia. N. Engl. J. Med. 2003;349:2387–2398. doi: 10.1056/NEJMoa030656. - DOI - PubMed
    1. Emberton M, Andriole GL, de la Rosette J, Djavan B, Hoefner K, Vela NR, et al. Benign prostatic hyperplasia: a progressive disease of aging men. Urology. 2003;61:267–273. doi: 10.1016/S0090-4295(02)02371-3. - DOI - PubMed
    1. Parsons JK. Modifiable risk factors for benign prostatic hyperplasia and lower urinary tract symptoms: new approaches to old problems. J. Urol. 2007;178:395–401. doi: 10.1016/j.juro.2007.03.103. - DOI - PubMed
    1. Griffiths K, Eaton CL, Harper ME, Peeling B, Davies P. Steroid hormones and the pathogenesis of benign prostatic hyperplasia. Eur. Urol. 1991;20(Suppl 1):68–77. doi: 10.1159/000471750. - DOI - PubMed
    1. Lunenfeld B. Androgen therapy in the aging male. World J. Urol. 2003;21:292–305. doi: 10.1007/s00345-003-0366-8. - DOI - PubMed

Publication types